Snowball logo
logo
4186

Taiwan Advance Bio-Pharmaceutical Inc.

4186 TWO
NT$8.87NT$0.00  (0%)
Estimate
P/E
28.6
EPS
0.31
Beta
0.359
About the company
Ticker
4186
ISIN
TW0004186002
Country
Taiwan
Sector (GICS)
Other
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA and rapid test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers stem cell banking services for newborn and adult stem cells storage; cell therapy programs; abused drugs rapid tests; operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company also involves in research, development, production, and sales of veterinary drug residue testing reagents, drug abuse certification testing services and management, detection, extraction, cryopreservation and storage, and gene testing services for umbilical cord blood stem cells, umbilical cord mesenchymal stem cells, peripheral blood stem cells, and related businesses. Taiwan Advance Bio-Pharmaceutical Inc. was founded in 1989 and is based in Taipei, Taiwan.

Frequently asked questions

What sector does Taiwan Advance Bio-Pharmaceutical Inc. (4186) operate in?

Taiwan Advance Bio-Pharmaceutical Inc. belongs to the Other sector and operates in the Biotechnology industry.

What is Taiwan Advance Bio-Pharmaceutical Inc. (4186) current stock price?

As of the latest data, Taiwan Advance Bio-Pharmaceutical Inc. stock price is NT$8.87, with a previous close of NT$8.87.

What is Taiwan Advance Bio-Pharmaceutical Inc. (4186) current market capitalization?

Taiwan Advance Bio-Pharmaceutical Inc. market cap is approximately 798.30 million.

What is Taiwan Advance Bio-Pharmaceutical Inc. (4186) Earnings Per Share (EPS)?

The trailing EPS is NT$0.31.

What is Taiwan Advance Bio-Pharmaceutical Inc. (4186) Price-to-Earnings (P/E) ratio?

Taiwan Advance Bio-Pharmaceutical Inc. current P/E ratio is 28.61.

Does Taiwan Advance Bio-Pharmaceutical Inc. (4186) pay dividends?

No. Taiwan Advance Bio-Pharmaceutical Inc. does not pay a dividend.

What is Taiwan Advance Bio-Pharmaceutical Inc. (4186) beta (volatility) score?

Taiwan Advance Bio-Pharmaceutical Inc. has a beta of 0.359, indicating lower volatility than the overall market.